--:--:--

Abbott India Limited

Web: abbott.co.in NSE: ABBOTINDIA BSE: 500488 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

25340 340(-1%)

Near 52W Low of 25135

Volume

4k as on 16, Oct

Open

34,340

High

30,186

Low

29,770

Close

25,680

VWAP

26,103

52 Week High

30,655

52 Week Low

25,135

Viand Research Rating
Quality Score

55/100

Growth Score

24/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

53,846

No. of Shares

2.12

P/E

45.27

P/B

16.52

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

36.48

ROCE

-

Profit Growth

-

Listing Date

08-Jan-10

Rank/Sector Rank

#189/#17

Promoter Holding

74.99%

FII Holding

0.38%

DII Holding

8.77%

Price Chart
Price Performance
1 Week1%
1 Month0%
3 Months6%
6 Months1%
1 Year13%
YTD8%
Moving Average
5 Day SMA26,004
10 Day SMA26,005
20 Day SMA26,512
30 Day SMA26,264
50 Day SMA26,484
61 Day SMA26,755
80 Day SMA26,756
200 Day SMA26,791
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 326,53026,15026,41026,505
Resistance 226,41026,12326,29926,398
Resistance 126,24026,09726,23126,215
Pivot Point26,12026,07026,12026,108
Support 125,95026,04326,00925,925
Support 225,83026,01725,94125,818
Support 325,66025,99025,83025,635
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,21,79317580%5%4%4%3755.50.0711509
2DIVISLAB2,43,22291622%0%45%38%6955.502568
3TORNTPHARM1,75,54746152%5%10%28%7255.51.792138
4ZYDUSLIFE1,13,21711350%1%20%12%2055.50.313560
5APOLLOHOSP1,09,34176042%9%4%1%5855.50.92003
6LAURUSLABS1,08,19820021%8%83%124%055.50.48890
7CIPLA1,07,52013312%2%8%19%2255.50.023862
8DRREDDY1,03,41412393%8%1%4%2055.50.24158
9MANKIND93,99322764%1%8%7%4955.50.391938
10AUROPHARMA92,68816112%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%(0.01) 74.99%
FIIs(0.11) 0.38%(0.11) 0.27%(0.01) 0.19%(0.01) 0.16%(0.01) 0.16%(0.01) 0.16%(0.01) 0.17%(0.01) 0.17%(0.01) 0.18%(0.01) 0.18%(0.01) 0.18%(0.01) 0.19%(0.01) 0.19%(0.01) 0.19%(0.01) 0.20%(0.01) 0.20%(0.01) 0.20%(0.01) 0.22%(0.01) 0.22%(0.01) 0.24%
DIIs(-0.21) 8.77%(-0.11) 8.93%(-0.11) 9.00%(-0.11) 9.11%(0.31) 9.18%(-0.11) 8.91%(0.01) 9.01%(0.21) 9.00%(-0.11) 8.81%(0.21) 8.91%(-0.11) 8.73%(0.11) 8.83%(0.21) 8.77%(0.21) 8.61%(0.51) 8.38%(-0.11) 7.85%(0.41) 7.95%(0.81) 7.52%(-0.11) 6.76%(0.01) 6.88%
Public15.85%15.81%15.83%15.74%15.67%15.94%15.85%15.86%16.01%15.92%16.09%16.01%16.05%16.20%16.42%16.95%16.86%17.27%18.04%17.89%
No. of Shareholders78,32075,86675,80171,19967,58469,93467,89269,44971,58869,38272,25268,88569,58272,08674,91583,52682,11390,56783,23673,417
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales18141710172417571738160516141633155814391437149414791343132213791304125512241222
Sales Growth % (YoY)4.3%6.5%6.8%7.6%11.6%11.5%12.3%9.3%5.3%7.1%8.7%8.3%13.4%7%8%12.9%7.1%14.5%11.8%15.8%
Sales Growth % (QoQ)6.1%-0.8%-1.9%1.1%8.3%-0.6%-1.2%4.8%8.3%0.1%-3.8%1%10.1%1.6%-4.1%5.8%3.9%2.5%0.2%-
Expenses12911229126112551293117611781194116711091049111311241063101010361034961955962
Operating Profit522481463502446429436439391330388381355280312343270294269260
OPM %2928272926272727252327252421242521232221
Other Income7576707073767260678156565650443427211918
Interest66586422333334444545
Depreciation2019191919181818181818181717181717171716
Profit before tax572531509546493483488479437390422415390308335355275292267257
Tax %2526262426242625252626252625262525282525
Net Profit 429395376415366367361359328287311313290231247266206211199192
Net Profit Growth % (QoQ)8.6%5.1%-9.4%13.4%-0.3%1.7%0.6%9.5%14.3%-7.7%-0.6%7.9%25.5%-6.5%-7.1%29.1%-2.4%6%3.6%-
Net Profit Growth % (YoY)17.2%7.6%4.2%15.6%11.6%27.9%16.1%14.7%13.1%24.2%25.9%17.7%40.8%9.5%24.1%38.5%----
TTM Net Profit16151552152415091453141513351285123912011145108110349509308828086023910
EPS in Rs201.66185.86176.93195.43172.18172.73169.78168.76154.36135.09146.35147.27136.59108.91116.16124.9596.7799.4993.7490.51
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Dec 2012Jan 1900
Sales692964095849534949194310409336793298290326142289227616532276
Sales Growth %8.1%9.6%9.4%8.7%14.1%5.3%11.3%11.5%13.6%11%14.2%0.6%37.7%10.9%-
Expenses503747144396414338323388333630742774250522501977200914512009
Operating Profit18921695145312061088922757605525398365312267202267
OPM %272625232221181616141414121212
Other Income2882752481547781114113117575048493349
Interest251112161918924230000
Depreciation767271706658601716161415221922
Profit before tax20791887161812741080926803699621436398344295215295
Tax %252526252625263635373634333333
Net Profit 155214141201949799691593450401277255229198145198
Net Profit Growth %9.8%17.7%26.6%18.8%15.6%16.5%31.8%12.2%44.8%8.6%11.4%15.7%36.6%-26.8%-
EPS in Rs730.39665.64565.3446.8375.87325.04279.04211.93188.82130.19120.12107.7593.3968.193.39
Dividend Payout %907173737385903129312929252525
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Dec 2012
Cash from Operating Activity131910121213893948727626499153307249215155101
Cash from Investing Activity-371182-416-148-396-72-401-257-215-155-77-187-144-59
Cash from Financing Activity-1066-925-745-639-637-582-217-143-102-90-80-58-42-42
Net Cash Flow-11826952107-8673899-1656291-30-311
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Dec 2012
Equity Capital21212121212121212121212121212121
Reserves4753399042123500367831672799258124101987167213661174916767626
Borrowings17218219760831131521531750000000
Other Liabilities15561501148714811411125412531086940932723679421436351260
Total Liabilities650256945917506351934556422438403547294124162066161613741139907
Fixed Assets331314336216225237271251270105811101089698109
CWIP62318131041121263411
Investments0000000000000000
Other Assets616553575563483449584315395235893275283523331950150512741040798
Total Assets650256945917506351934556422438403547294124162066161613741139907
Delivery

Delivery Data: ABBOTINDIA

#Date
25135
11%
27850
Value (Cr)Q/T
3
Del
55
Del
36
122-Oct25360
6
1463
221-Oct25680
9
2625
319-Oct25905
5
2493
416-Oct26170
10
1646
515-Oct26070
8
2484
614-Oct26295
16
2518
713-Oct25695
7
2624
812-Oct25790
7
2524
99-Oct26000
9
2535
108-Oct25580
14
2487
117-Oct26095
23
47417
126-Oct26115
33
36722
135-Oct26240
15
2437
141-Oct26840
18
15510
1530-Sep27125
15
2477
1629-Sep27270
56
23319
1728-Sep26740
15
2467
1825-Sep26955
6
2483
1924-Sep26860
12
2415
2023-Sep26935
12
2537
2122-Sep27225
12
2627
2221-Sep26960
20
25611
2318-Sep27270
104
36769
2417-Sep25910
13
2497
2516-Sep26125
15
2548
2615-Sep26125
28
25215
2711-Sep25550
24
25513
2810-Sep25260
18
2519
299-Sep25225
15
26610
308-Sep25555
28
25917
317-Sep25940
14
2497
324-Sep26065
23
24410
333-Sep25945
8
2575
342-Sep26045
20
25211
351-Sep26135
23
24310
3631-Aug25850
17
15710
3728-Aug26175
17
1549
3827-Aug26350
12
2567
3926-Aug26555
17
26411
4025-Aug26415
29
37722
4124-Aug26420
27
24312
4221-Aug26230
23
25813
4320-Aug26120
20
26413
4419-Aug26405
20
26012
4518-Aug26580
12
2526
4617-Aug26905
30
35918
4714-Aug27060
50
37638
Daily Market Cap
DateTotal Market CapChangeChg %
22-Oct53,846c1,084c1.97
21-Oct54,929c298c0.54
19-Oct55,227c446c0.80
17-Oct55,673c00
16-Oct55,673c404c0.73
15-Oct55,269c21c0.04
14-Oct55,248c669c1.23
13-Oct54,579c244c0.45
12-Oct54,823c234c0.42
09-Oct55,057c808c1.49
08-Oct54,250c1,264c2.28
06-Oct55,514c1,179c2.08
05-Oct56,693c1,116c1.93
01-Oct57,809c308c0.53
29-Sep58,117c1,233c2.17
28-Sep56,884c319c0.56
25-Sep57,203c202c0.35
24-Sep57,405c542c0.94
22-Sep57,947c2,624c4.74
17-Sep55,323c191c0.34
16-Sep55,514c1,711c3.18
10-Sep53,803c00
Stock Checklist
Price is above from 52 week high low average: 4%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 272 fund scheme(s) across 31 fund house(s) as of Oct26 · Total value ₹8,645 Cr · 169 increasing / 42 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
SBI Mutual Fund101.59%+0.17%1734.9
Nippon India Mutual Fund120.95%+0.11%1444.3
Canara Robeco Mutual Fund120.90%+0.12%1168.9
Tata Mutual Fund221.69%+0.24%1050.3
Axis Mutual Fund61.09%+0.10%745.5
ICICI Prudential Mutual Fund141.91%+0.15%402.9
Aditya Birla Sun Life Mutual Fund140.87%+0.44%298.9
Bank of India Mutual Fund132.06%+0.15%260.3
PGIM India Mutual Fund100.92%+0.04%242.8
LIC Mutual Fund121.56%+0.14%187.5
WhiteOak Capital Mutual Fund120.63%-0.06%182.7
Edelweiss Mutual Fund160.40%+0.03%154.6
DSP Mutual Fund140.81%+0.04%115.5
Baroda BNP Paribas Mutual Fund81.63%+0.22%115.1
Bandhan Mutual Fund140.18%-0.06%111.8
UTI Mutual Fund100.55%+1.09%107.1
360 ONE Mutual Fund41.18%+0.07%80.9
Motilal Oswal Mutual Fund160.27%+0.25%62.7
NJ Mutual Fund60.47%+0.14%57.6
ITI Mutual Fund61.13%-0.06%46.8
HSBC Mutual Fund40.08%+0.01%27.7
Kotak Mahindra Mutual Fund41.14%+0.14%16.6
Taurus Mutual Fund24.33%+0.27%11.9
HDFC Mutual Fund80.20%+0.02%7.8
Zerodha Mutual Fund40.17%+0.01%3.3
Navi Mutual Fund60.33%+0.04%2.8
PGIM India Asset Management Private Limite11.20%+0.10%2.1
Jio BlackRock Mutual Fund20.26%+0.03%1.1
Groww Mutual Fund40.08%+0.02%0.6
Mirae Asset Mutual Fund40.12%+0.01%0.2
Angel One Mutual Fund20.07%-0.1
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0